{"blog": [], "keywords": [{"value": "Acquired Immune Deficiency Syndrome", "name": "subject", "rank": "1", "is_major": "Y"}, {"value": "GlaxoSmithKline PLC", "name": "organizations", "rank": "2", "is_major": "Y"}, {"value": "Colleges and Universities", "name": "subject", "rank": "3", "is_major": "Y"}, {"value": "Research", "name": "subject", "rank": "4", "is_major": "N"}, {"value": "Drugs (Pharmaceuticals)", "name": "subject", "rank": "5", "is_major": "N"}, {"value": "University of North Carolina", "name": "organizations", "rank": "6", "is_major": "Y"}, {"value": "Qura Therapeutics LLC", "name": "organizations", "rank": "7", "is_major": "N"}, {"value": "Margolis, David M (1959- )", "name": "persons", "rank": "8", "is_major": "N"}], "web_url": "http://www.nytimes.com/2015/05/11/business/drugmaker-and-university-ally-to-seek-cure-for-aids.html", "document_type": "article", "byline": {"person": [{"lastname": "POLLACK", "firstname": "Andrew", "role": "reported", "organization": "", "rank": 1}], "original": "By ANDREW POLLACK", "contributor": ""}, "type_of_material": "News", "multimedia": [{"url": "images/2015/05/11/business/11AIDS/11AIDS-thumbWide.jpg", "legacy": {"wide": "images/2015/05/11/business/11AIDS/11AIDS-thumbWide.jpg", "wideheight": "126", "widewidth": "190"}, "subtype": "wide", "type": "image", "width": 190, "height": 126}, {"url": "images/2015/05/11/business/11AIDS/11AIDS-articleLarge.jpg", "legacy": {"xlarge": "images/2015/05/11/business/11AIDS/11AIDS-articleLarge.jpg", "xlargeheight": "558", "xlargewidth": "600"}, "subtype": "xlarge", "type": "image", "width": 600, "height": 558}, {"url": "images/2015/05/11/business/11AIDS/11AIDS-thumbStandard.jpg", "legacy": {"thumbnail": "images/2015/05/11/business/11AIDS/11AIDS-thumbStandard.jpg", "thumbnailheight": "75", "thumbnailwidth": "75"}, "subtype": "thumbnail", "type": "image", "width": 75, "height": 75}], "section_name": "Business Day", "word_count": "630", "source": "The New York Times", "subsection_name": null, "lead_paragraph": "GlaxoSmithKline will contribute a total of $20 million to start a research institute and a company with the goal of curing patients infected with H.I.V.", "pub_date": "2015-05-11T00:00:00Z", "news_desk": "Business", "headline": {"print_headline": "Drugmaker and University Ally to Seek Cure for AIDS", "main": "Drugmaker and University Ally to Seek Cure for AIDS"}, "print_page": "8", "snippet": "GlaxoSmithKline will contribute a total of $20 million to start a research institute and a company with the goal of curing patients infected with H.I.V.", "_id": "55500d3238f0d835cf3efa25", "slideshow_credits": null, "abstract": "GlaxoSmithKline will partner with University of North Carolina at Chapel Hill to launch research institute and company that will seek to cure HIV infection and AIDS, move previously considered impossible by scientists; program at UNC will be led by Dr David Margolis."}